X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (48) 48
humans (46) 46
index medicus (44) 44
cardiac & cardiovascular systems (34) 34
abridged index medicus (33) 33
male (33) 33
female (32) 32
internal medicine (26) 26
mortality (25) 25
cardiovascular disease (23) 23
middle aged (22) 22
risk factors (22) 22
heart attacks (21) 21
aged (19) 19
diabetes (18) 18
coronary heart disease (15) 15
outcomes (15) 15
atherosclerosis (13) 13
cardiology and cardiovascular medicine (13) 13
cholesterol (13) 13
drug therapy (13) 13
adult (12) 12
clinical trials (12) 12
prognosis (12) 12
cardiology (11) 11
follow-up studies (11) 11
cardiac patients (10) 10
confidence intervals (10) 10
statins (10) 10
cardiovascular diseases (9) 9
care and treatment (9) 9
analysis (8) 8
article (8) 8
impact (8) 8
incidence (8) 8
medical colleges (8) 8
prospective studies (8) 8
risk assessment (8) 8
studies (8) 8
blood pressure (7) 7
coronary artery bypass (7) 7
diabetics (7) 7
medical research (7) 7
medicine, general & internal (7) 7
patients (7) 7
risk (7) 7
sects (7) 7
treatment outcome (7) 7
acute myocardial-infarction (6) 6
body mass index (6) 6
chest pain (6) 6
coronary vessels (6) 6
electrocardiography (6) 6
hospitals (6) 6
inflammation (6) 6
intervention (6) 6
low density lipoproteins (6) 6
myocardial-infarction (6) 6
prevention (6) 6
research (6) 6
retrospective studies (6) 6
stroke (6) 6
time factors (6) 6
acute coronary syndromes (5) 5
aged, 80 and over (5) 5
aspirin (5) 5
association (5) 5
cardiovascular-disease (5) 5
cholesterol, ldl - blood (5) 5
coronary artery disease - diagnosis (5) 5
diabetes mellitus (5) 5
diagnosis (5) 5
myocardial infarction - epidemiology (5) 5
percutaneous coronary intervention (5) 5
prevalence (5) 5
revascularization (5) 5
survival analysis (5) 5
transluminal angioplasty (5) 5
trial (5) 5
united states - epidemiology (5) 5
adults (4) 4
angioplasty (4) 4
angioplasty, balloon, coronary (4) 4
cardiovascular agents (4) 4
clinical outcomes (4) 4
coronary artery disease (4) 4
coronary artery disease - complications (4) 4
coronary-heart-disease (4) 4
diabetes therapy (4) 4
double-blind method (4) 4
drug-eluting stents (4) 4
global health (4) 4
health aspects (4) 4
health knowledge, attitudes, practice (4) 4
hypertension (4) 4
hypotheses (4) 4
metaanalysis (4) 4
obesity (4) 4
patient outcomes (4) 4
physicians (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 6, pp. 812 - 813
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 14, pp. 1672 - 1673
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 10, pp. 969 - 970
  Even more disconcerting is that only 40% of family physicians, internists, and cardiologists used the assessment tool when assessing the prognosis of... 
Cardiovascular | Internal Medicine | Cardiovascular diseases | Mens health | Womens health | Physicians | Cardiovascular disease | Blood pressure | Diabetes | Health risk assessment | Patients | Cholesterol | Statins | Age | Risk factors
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2015, Volume 128, Issue 7, pp. e19 - e19
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2009, Volume 122, Issue 3, pp. e15 - e15
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 5, pp. 1489 - 1495.e5
Abstract Background EXCELS was a postmarketing commitment to the US Food and Drug Administration to assess long-term safety of omalizumab in an observational... 
Allergy and Immunology | arterial thromboembolic event | safety | serious adverse event | Adverse event | clinical trials | omalizumab | moderate to severe asthma | EXHALED BREATH CONDENSATE | GLUCOCORTICOIDS | RISK | SEVERE ALLERGIC-ASTHMA | IMMUNOLOGY | ADULT-ONSET ASTHMA | ALLERGY | ANTIIMMUNOGLOBULIN-E THERAPY | SEVERE PERSISTENT ASTHMA | ACUTE MYOCARDIAL-INFARCTION | CORONARY-HEART-DISEASE | ANTI-IGE ANTIBODY | Anti-Asthmatic Agents - adverse effects | Prospective Studies | Omalizumab - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Male | Asthma - drug therapy | Incidence | Cardiovascular Diseases - epidemiology | Product Surveillance, Postmarketing | Adult | Female | Omalizumab - therapeutic use | Cerebrovascular Disorders - epidemiology | Asthma - epidemiology | Health maintenance organizations | Pharmaceutical industry | Asthma in children | Stroke (Disease) | Thromboembolism | Analysis | Asthma | Myocardial infarction | Heart | Corticoids | C-reactive protein | Glucocorticoids | Adjudication | Cardiovascular disease | Risk factors | Cerebrovascular system | Motivation | Condensates | Flutter | Chronic obstructive pulmonary disease | Diagnosis | Cross sections | Emergency medical services | Cerebral infarction | Corticosteroids | Mortality | Assessments | Patients | Thrombosis | Quality of life | Side effects | Rheumatoid arthritis | Arteriosclerosis | Monoclonal antibodies | Death | Skin | Cardiovascular diseases | Circulation | Health care | Intervention | Transient ischemic attack | Identification methods | Congenital defects | Medical services | Clinical trials | Immunoglobulin E | Population studies | Arthritis | Malignancy | Angina | Congestive heart failure | Hemorrhage | Risk assessment | Safety engineering | Atherosclerosis | Patient safety | Safety | Drug therapy | Age | Cardiovascular system | Hypertension | Stroke | Statistical analysis | Complications | Hypersensitivity | Diabetes mellitus | Coronary artery disease | Ventricle | Respiration | Pharmaceuticals
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2008, Volume 121, Issue 9, pp. 748 - 757
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 15, pp. 1607 - 1615
Objectives This study evaluated data from 3 federally funded trials that focused on optimal medical therapy to determine if formalized attempts at risk factor... 
Cardiovascular | Internal Medicine | risk factor | clinical trials | secondary prevention | MORTALITY | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | POLYPILL | ADULTS | OPTIMAL MEDICAL THERAPY | ADHERENCE | STROKE | IMPACT | OUTCOMES UTILIZING REVASCULARIZATION | CARDIOVASCULAR-DISEASE | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Male | Secondary Prevention - methods | Coronary Artery Disease - blood | Diabetes Mellitus, Type 2 - epidemiology | Diabetes Mellitus, Type 2 - therapy | Cholesterol, LDL - blood | Female | Hypoglycemic Agents - therapeutic use | Effect Modifier, Epidemiologic | Coronary Artery Bypass - methods | Risk Reduction Behavior | Comorbidity | Angioplasty, Balloon, Coronary - methods | Risk Factors | Coronary Artery Disease - prevention & control | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Outcome and Process Assessment (Health Care) | Coronary Artery Disease - therapy | Monitoring, Physiologic - methods | Aged | Coronary Artery Disease - epidemiology | Coronary Artery Disease - psychology | Practice Guidelines as Topic | Smoking Cessation | Sects | Diabetics | Medical colleges | Low density lipoproteins | Clinical trials | Hemoglobin | Diabetes | Coronary heart disease | Hospitals, Veterans | Cholesterol | Infection control | Medical research | Heart attacks | Drug therapy | Cardiology | Coronary vessels
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2014, Volume 30, Issue 8, pp. 837 - 849
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 10, pp. 985 - 995
Journal Article